Multimodal Tracking of Theranostic Nanoparticles with CAR T Immunotherapy for Non-Hodgkin Lymphoma

Radiol Imaging Cancer. 2022 Jul;4(4):e229015. doi: 10.1148/rycan.229015.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Immunotherapy
  • Lymphoma, Non-Hodgkin* / diagnostic imaging
  • Lymphoma, Non-Hodgkin* / pathology
  • Lymphoma, Non-Hodgkin* / therapy
  • Nanoparticles* / therapeutic use
  • Precision Medicine
  • Receptors, Chimeric Antigen*

Substances

  • Receptors, Chimeric Antigen